by European Public Health Alliance | Jun 29, 2021 | #VaccineEquity, Health Inequalities, Health Inequalities | Publications
EPHA publishes new recommendations to ensure vaccine equity across the EUIn the light of a more comprehensive and global vision of health, the current pandemic has proven to intensify many pre-existing social and health disparities worldwide as well as within the...
by EPHA | May 21, 2021 | Universal Access and Affordable Medicines | Latest Developments
“When my son was diagnosed with cancer, he was treated with old, off-label drugs. The same happened two years later when he relapsed two years later, despite a poor prognosis. Not a single experimental drug was on trial to give us hope. We have to change this...
by European Public Health Alliance | Mar 23, 2021 | #CleanAirHealthyCities, Clean Air | Latest Developments
EPHA is calling on mayors across Europe to tackle growing levels of air pollution by further restricting traffic in urban centres, a demand based on a wide-ranging new transport study.The report on Air pollution & transport policies at the city level, conducted by...
by Radost Zaharieva | Dec 10, 2020 | Health Inequalities, Health Inequalities | Publications
On 10th December we celebrate the anniversary of the Universal Declaration of Human Rights adopted by the United Nations in 1948, three years after the end of the Second World War. The Universal Declaration of Human Rights is a milestone for European history,...
by European Public Health Alliance | Nov 10, 2020 | Universal Access and Affordable Medicines | Latest Developments, Universal Access and Affordable Medicines | Publications
What do we know when a new medicine is approved? What are the regulatory requirements for new medicines? What happens once a new drug is on the market?Following the first of the EPHA #A2MDialogues, our panelists Andrea Cipriani, Lydie Meheus, Huseyin Naci and Beate...
